Cargando…
Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomas
Aneuploidy is the hallmark of malignancy. Our previous study successfully detected nonhematogenic circulating aneuploidy cells (CACs) in types of gliomas. The current prospective clinical study aims to further precisely subcategorize aneuploid CACs, including CD31(−) circulating tumor cells (CTCs) a...
Autores principales: | Li, Mingxiao, Gao, Faliang, Ren, Xiaohui, Dong, Gehong, Chen, Hongyan, Lin, Alexander Y., Wang, Daisy Dandan, Liu, Mingyang, Lin, Peter Ping, Shen, Shaoping, Jiang, Haihui, Yang, Chuanwei, Zhang, Xiaokang, Zhao, Xuzhe, Zhu, Qinghui, Li, Ming, Cui, Yong, Lin, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530864/ https://www.ncbi.nlm.nih.gov/pubmed/35940591 http://dx.doi.org/10.1111/cas.15516 |
Ejemplares similares
-
Combination of Immunotherapy and Radiotherapy for Recurrent Malignant Gliomas: Results From a Prospective Study
por: Jiang, Haihui, et al.
Publicado: (2021) -
Orelabrutinib Combined With Lenalidomide and Immunochemotherapy for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Retrospective Analysis of Case Series
por: Yang, Chuanwei, et al.
Publicado: (2022) -
Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features
por: Li, Mingxiao, et al.
Publicado: (2021) -
Corrigendum: Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and Molecular Features
por: Li, Mingxiao, et al.
Publicado: (2021) -
Combining MGMT promoter pyrosequencing and protein expression to optimize prognosis stratification in glioblastoma
por: Li, Mingxiao, et al.
Publicado: (2021)